Lupin Receives Tentative Approval from U.S. FDA for Novel Apixaban Oral Suspension

MUMBAI, India and NAPLES, Fla., Sept. 28, 2026 // -- Global pharmaceutical leader Lupin Limited (Lupin) (BSE: 500257) (NSE:LUPIN) (REUTERS: LUPIN.BO) (BLOOMBERG: LPCIN) today announced that it has received tentative approval from the United States Food and Drug Administration (U.S. FDA) f…